Stefan Glombitza
Algemeen Directeur bij FORMYCON AG
Actieve functies van Stefan Glombitza
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FORMYCON AG | Algemeen Directeur | 01-07-2022 | - |
| Operationeel Directeur | 01-10-2016 | 01-07-2022 |
Loopbaan van Stefan Glombitza
Eerdere bekende functies van Stefan Glombitza
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | 01-01-1995 | - |
Opleiding van Stefan Glombitza
| University of Regensburg | Doctorate Degree |
Statistieken
Internationaal
| Duitsland | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
- Beurs
- Insiders
- Stefan Glombitza
- Ervaring
